Table 4.
30-day outcomes prior and post-Benchmark implementation by country
| Outcome, n (%) | France (prior n = 322, post n = 568) |
p value | Spain (prior n = 206, post n = 248) |
p value | Germany (prior n = 127, post n = 235) |
p value | Italy (prior n = 98, post n = 202) |
p value | Austria (prior n = 67, post n = 109) |
p value | p valuea | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Combined end pointb | Prior | 3 (1.1) | 0.560 | 5 (2.4) | 0.326 | 2 (1.7) | 1.000 | 2 (2.2) | 0.683 | 2 (3.4) | 0.126 | |
| Post | 10 (1.9) | 10 (4.1) | 5 (2.4) | 4 (4.3) | 0 (0.0) | 0.094 | ||||||
| All-cause mortality | Prior | 0 (0.0) | 0.305 | 1 (0.5) | 1.000 | 0 (0.0) | 0.531 | 1 (1.1) | 0.492 | 0 (0.0) | – | |
| Post | 4 (0.8) | 1 (0.4) | 2 (1.0) | 0 (0.0) | 0 (0.0) | 0.913 | ||||||
| Stroke/TIA | Prior | 2 (0.8) | 1.000 | 3 (1.5) | 0.518 | 2 (1.7) | 1.000 | 2 (2.2) | 0.683 | 1 (1.7) | 0.358 | |
| Post | 5 (1.0) | 6 (2.5) | 3 (1.4) | 4 (4.2) | 0 (0.0) | 0.074 | ||||||
| Life-threatening bleeding | Prior | 2 (0.8) | 0.606 | 5 (2.4) | 0.439 | 1 (0.9) | 1.000 | 2 (2.2) | 1.000 | 1 (1.7) | 1.000 | |
| Post | 2 (0.4) | 9 (3.7) | 1 (0.5) | 3 (3.2) | 1 (0.9) | 0.002 | ||||||
| AKI (stage 2/3, incl. dialysis) | Prior | 0 (0.0) | – | 4 (2.0) | 1.000 | 0 (0.0) | – | 0 (0.0) | 0.497 | 0 (0.0) | 0.538 | |
| Post | 0 (0.0) | 4 (1.7) | 0 (0.0) | 2 (2.2) | 2 (1.9) | 0.002 | ||||||
| Coronary obstruction requiring intervention | Prior | 1 (0.4) | 0.337 | 1 (0.5) | 1.000 | 3 (2.6) | 0.671 | 0 (0.0) | 1.000 | 0 (0.0) | – | |
| Post | 0 (0.0) | 1 (0.4) | 3 (1.5) | 1 (1.1) | 0 (0.0) | 0.033 | ||||||
| Major vascular complications | Prior | 6 (2.3) | 0.603 | 9 (4.4) | 0.937 | 7 (5.9) | < 0.001 | 6 (6.7) | 0.528 | 4 (6.8) | 0.056 | |
| Post | 9 (1.7) | 11 (4.5) | 0 (0.0) | 4 (4.3) | 1 (0.9) | 0.004 | ||||||
| Re-hospitalization (all-cause) | Prior | 8 (3.0) | 0.746 | 9 (3.7) | 0.650 | 2 (1.7) | 0.716 | 0 (0.0) | 1.000 | 2 (3.4) | 0.618 | |
| Post | 18 (3.5) | 6 (2.9) | 6 (2.9) | 0 (0.0) | 2 (1.9) | 0.393 |
Bold formatting indicates statistical significance
AKI acute kidney injury, TIA transitory ischaemic attack, pts patients
aCross-country comparison post-Benchmark implementation (Chi-squared or Fisher’s exact test)
bIncludes all-cause mortality, stroke/TIA, and valve-related re-hospitalization[27]